NextCell Pharma AB is a Swedish AB based in Huddinge, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2014, the company reported revenue of 7,6 mn kr in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att (i) driva vävnadsinrättningar, biobank och FOU-arbete med stamceller (ii) erbjuda tjänster för långtidsförvaring av stamceller (iii) löpande förvalta lös och fast egendom, samt därmed förenlig verksamhet.
In its most recent annual report (2025), NextCell Pharma AB reported revenue of 7,6 mn kr, a decrease of 29% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of 37,4 mn kr, and the EBITDA margin stood at -459.1%.
At the end of 2025, equity financed 71.7% of the balance sheet, and current assets covered short-term debt 2.4 times.
Frequently asked questions
What is the Org number of NextCell Pharma AB?
NextCell Pharma AB is registered with Bolagsverket / SCB under Org 5569658361.
What is the revenue of NextCell Pharma AB?
NextCell Pharma AB reported revenue of 7,6 mn kr in 2025.
Who is the CEO of NextCell Pharma AB?
Mathias Gösta Svahn is the CEO of NextCell Pharma AB, in role since 2019.
Who is the chairman of NextCell Pharma AB?
Hans Peter Torsten Ekre chairs the board of NextCell Pharma AB, in role since 2024.
Where is NextCell Pharma AB headquartered?
NextCell Pharma AB's registered address is Hälsovägen 7 8tr.
